Replies to post #215245 on Innovation Pharmaceuticals Inc (IPIX)

[Suvorov]

The authorised $10MM Preferred is a potential problem.

Many shareholders are excited over the IPIX's chances but the stock chart doesn't exude the same enthusiasm: THE chart looks horrible.

IPIX might get its goal, but may have difficulties getting there where insider exchange their debts of the preferred, make them convertible which dilutes all common shareholders.

This happens all the time with penny stocks without cash flow, like IPIX.

This may never happen to IPX; though as long as the 10MM preferred are authorised the risk remains regardless of how many shareholders thing that it is not.

Due your own DD .

In my opinion.